VISTA
INTELLECTUAL PROPERTY
Vista controls the landscape of nanowires for predictions, assessment and diagnosis of organ injury, in any setting, caused by any agent or treatment. Thus, Vista is uniquely positioned to utilize its commitment and expertise in the commercialization of nanotechnology-based products for the health sciences.
More specifically, Vista has world-wide exclusive rights to several broad patents issued around nanowires:
| • | Nanowires as Field Effect Transistors (09/935,776, and 10/020,004) |
| • | High Sensitivity Nanowire Sensors (60/860,586 filed 11/02/06) |
| • | NanoBioSensors and Related Technologies (60/812,884, filed 6/12/06) |
| • | Nanoscale Wire Devices and Methods (60/790,322, filed 4/07/06, PCT filed 4/06/07) |
| • | Nanobioelectronics (60/783,203, filed 3/15/06, PCT/US2007/006545, filed 3/15/07) |
| • | Nanoscale Sensors: Multiplexed, Electrical Detection of Cancer Markers Using Nanowire Sensor Arrays (US only 11/501,466 with priority to 8/09/05) |
Multiple
additional applications will filed around At-Home tox assays, predictions
of disease risk, and nanowire technologies.
